AcusMu Microneedle Patch
Clinical Trials- Indications
- Periorbital wrinkles, Skin diseases
Company intelligence / Profile preview
AcusMu Medtech
Taipei, Taiwan
- Ownership
- Private
- Development stage
- Other
01
Overview
AcusMu Medtech is developing dissolvable microneedle patches for transdermal delivery of drugs, vaccines, and cosmetic ingredients. Their FMD WK patch is undergoing a randomized, double-blind clinical trial to assess efficacy in reducing periorbital wrinkles. The company’s technology enables efficient skin penetration and large molecule delivery without pain or cold chain requirements[2][7]. No published pivotal results yet; development includes prototypes for co-development with pharma partners.
- Therapeutic areas
- OtherDermatology
- Modalities
- DeviceBiologic (for drug/vaccine delivery via microneedle patch)Peptides (as example of delivered agents)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on AcusMu Medtech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AcusMu Medtech.